Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Diabetomics, Inc., announced the granting of an Emergency Use Authorization (EUA) by the US Food and Drug Administration for the Company's CovAb™ SARS-CoV-2 Ab point-of-care test. The product had also...
read more
his system has been designed to eliminate RNase A from Covid-19 rt-PCR test kits. The need for disinfection technology more apparent than ever after the 2020 global health crisis, Phoseon has built ...
read more
The U.S. FDA issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) for the treatment of hospitalized adults and pediatric patients (2 years of age and older) who are receiving...
read more
Oxford-led COV001 and COV002 trials showed that Vaxzevria induced a strong immune response following a long second dose interval (up to 45 weeks) and after a third booster dose. The results also ...
read more
The first participants in a Phase II/III trial for the new COVID-19 variant vaccine AZD2816 have been vaccinated to assess safety and immunogenicity in both previously vaccinated and unvaccinated ...
read more
NRx Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative™ have begun treating patients with inhaled ZYESAMIÔ (Aviptadil), in the I-SPY COVID Trial (NCT04488081), a phase 2 adaptive platform...
read more
FlowMetric Life Sciences Inc., a globally recognized life sciences company, announces the launch of VaxEffect™ COVID-19 Vaccine Immune Response Test, a unique and powerful platform exclusively created...
read more
Seegene Inc announced the launch of a new SARS-CoV-2 variant diagnostic test capable of screening newly emerging virus variants including the Delta and the Delta Plus that have become the dominant ...
read more
Two new studies propose the first model for diagnosing, indexing and monitoring Post-Acute Sequelae of COVID-19 (PASC), also known as long COVID or long haul COVID. Long COVID is believed to affect as...
read more
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients, for the supply ...
read more
Pfizer Inc. and BioNTech SE announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac”, a Cape Town-based, South African biopharmaceutical company, to ...
read more
Pfizer Inc. and BioNTech SE announced that the U.S. government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. These doses are expected to be delivered from ...
read more
The incidence of very rare thromboembolic events was far lower than in people diagnosed with COVID-19 infection. In a large real-world study, data published as a pre-print on The Lancet server from ...
read more
The U.S. FDA revised the Emergency Use Authorization (EUA) for baricitinib (sold under the brand name Olumiant) now authorizing baricitinib alone for the treatment of COVID-19 in hospitalized adults ...
read more
Rho, a full-service contract research organization (CRO), announced its Human Epidemiology and Response to SARS-CoV-2 (HEROS) study, to help determine the rate of the new coronavirus infection in ...
read more